Office Headquarters: (610) 544-3500

perirx log in button

PeriRx Logo

 

Get News and Updates

 

eco

CLIA: 39D2085645

PeriRx on Facebook PeriRx on YouTube PeriRx on Google+ Stephen M. Swanick LinkedIn

ny

New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval. 

Monthly Archives: September 2015

Decade of Research Supports Salivary Oral Cancer Test

Steve and JackMore than 47,000 Americans will be diagnosed with oral or pharyngeal cancer this year, according to the National Cancer Institute. When caught early, survival rates can reach 80% to 90%. But oral cancer often isn’t diagnosed until it is too late, leading to more than 8,650 deaths annually. Researchers at PeriRx, LLC believe their SaliMark OSCC salivary test, which is now on the market, can dramatically improve those numbers and save thousands of lives. [Read more…]

Salivary Test for Oral Cancer Now Available

DrBicuspid logoOral squamous cell carcinoma (OSCC) is the sixth leading cancer worldwide and the fourth in African-American men. The mortality of this disease has not significantly improved in decades and this is largely due to late diagnosis. A new salivary test can help improve these statistics. [Read more…]

OSCC Salivary Test Now Available

SaliMark-Branded Box with ReportNearly 45,750 Americans will be diagnosed with oral or pharyngeal cancer this year, according to the Oral Cancer Foundation. In 5 years, only slightly more than half of those patients will still be alive. The high rate of mortality is due to late diagnosis of the disease, which typically isn’t noticed until it has reached stage III or IV.

PeriRx LCC hopes to change that with SaliMark OSCC, which clinicians can use to screen patients for oral squamous cell carcinoma (OSCC). The easy to use yet advanced molecular DNA salivary test is now available from the online ordering systems of Benco Dental, Henry Schein Dental, and Patterson Dental. [Read more…]

Launching Saliva Detection Test for Oral Cancer, PeriRx Sees Opportunity for Early-Stage Disease Dx

Genomeweb  logoNEW YORK (GenomeWeb) — PeriRx, a Pennsylvania-based developer of non-invasive oral diagnostic technology, has launched SaliMark OSCC, which it said is the first commercial saliva test for the early detection of oral squamous cell carcinoma.

The test kit contains biomarkers identified in an initial study done by the Early Detection Research Network (EDRN), an initiative of the National Cancer Institute. The biomarkers and the test were pre-validated by David Wong, a professor in the University of California at Los Angeles’ School of Dentistry. [Read more…]

Delco company’s test kit targets oral cancer

delcotimesA Delaware County personalized medicine company has launched its first product: a DNA test kit developed for the early detection of oral cancer. PeriRx’s SaliMark salivary test kits are now available from the online ordering systems of dental product distributors Henry Schein Dental, Patterson Dental and Benco Dental. The test is priced at $160. [Read more…]